EBM Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bylund, A.
Right arrow Articles by Mäkela, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bylund, A.
Right arrow Articles by Mäkela, S.
Experimental Biology and Medicine 230:217-223 (2005)
© 2005 Society for Experimental Biology and Medicine


ORIGINAL RESEARCH ARTICLE

Anticancer Effects of a Plant Lignan 7-Hydroxymatairesinol on a Prostate Cancer Model In Vivo

Annika Bylund*,2, Niina Saarinen{dagger},2, Jie-Xian Zhang{ddagger}, Anders Bergh§, Anders Widmark||, Anders Johansson{ddagger}, Eva Lundin§, Herman Adlercreutz, Göran Hallmans{ddagger}, Pär Stattin§ and Sari Mäkela{dagger},1

* Department of Community Medicine and Rehabilitation Geriatric Medicine, Umeå University Hospital, S-901 87 Umeå, Sweden; {dagger} University of Turku, Functional Foods Forum and Institute of Biomedicine, University of Turku, FI-20014 Turku, Finland; {ddagger} Department of Public Health and Clinical Medicine, Nutritional Research, Umeå University, S-901 87 Umeå, Sweden; § Department of Medical Biosciences, Pathology, Umeå University Hospital, S-901 87 Umeå, Sweden; || Department of Oncology, Umeå University Hospital, S-901 87 Umeå, Sweden; Department of Clinical Chemistry, Institute for Preventive Medicine, Nutrition and Cancer, Folkhälsan Research Center, and University of Helsinki, FI-00014 Helsinki, Finland

To whom requests for reprints should be addressed at 1 University of Turku, Functional Foods Forum, FI-20014 Turku, Finland. E-mail: sarmak{at}utu.fi

Clinical intervention studies and experimental studies with lignan-rich diets suggest that lignans may have inhibitory effects on prostate cancer, but no clinical or experimental studies with purified lignans have been published. The purpose of this study was to investigate the effect of a plant lignan 7-hydroxymatairesinol (HMR) on LNCaP human prostate cancer xenografts in athymic mice. Athymic nude male mice were injected subcutaneously with LNCaP cells. Starting 3 days after tumor cell injections, a control diet or a control diet supplemented with 0.15% or 0.30% of HMR was administered to mice and the tumor take rate and growth was observed for 9 weeks. HMR diet inhibited the growth of LNCaP tumors. Mice treated with HMR had smaller tumor volume, lower tumor take rate, increased proportion of nongrowing tumors, and higher tumor cell apoptotic index compared with controls. Furthermore, the cell proliferation index was reduced in mice receiving the 0.30% HMR diet compared with mice receiving the control diet. Our results suggest that dietary HMR started at the early phase of the tumor development inhibits the growth of the LNCaP human prostate cancer xenografts in athymic male mice.

Key Words: phytoestrogens • 7-hydroxymatairesinol • diet • LNCaP human prostate adenocarcinoma • athymic nude mice




This article has been cited by other articles:


Home page
Molecular Cancer TherapeuticsHome page
L.-H. Chen, J. Fang, H. Li, W. Demark-Wahnefried, and X. Lin
Enterolactone induces apoptosis in human prostate carcinoma LNCaP cells via a mitochondrial-mediated, caspase-dependent pathway
Mol. Cancer Ther., September 1, 2007; 6(9): 2581 - 2590.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by the Society for Experimental Biology and Medicine.